BCR-ABL causes over-expression of Cyclin D2 in B-lymphoblasts.

被引：0
|
作者：
Deininger, MWN
Goldman, JM
Peters, G
Melo, JV
机构：
[1] Hammersmith Hosp, ICSTM, Dept Haematol, London, England
[2] Imperial Canc Res Fund Labs, London, England
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
884
引用
收藏
页码：216A / 217A
页数：2
相关论文
共 50 条
  • [21] Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development
    Solvason, N
    Wu, WW
    Parry, D
    Mahony, D
    Lam, EWF
    Glassford, J
    Klaus, GGB
    Sicinski, P
    Weinberg, R
    Liu, YJ
    Howard, M
    Lees, E
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (05) : 631 - 638
  • [22] Characterization of Cyclin D2 Expression in Human Endometrium
    DooSeok Choi
    Sarah Yoon
    EunYoung Lee
    SeongSoo Hwang
    SangYong Song
    JiYoung Kim
    Byung-Koo Yoon
    Je-Ho Lee
    The Journal of the Society for Gynecologic Investigation: JSGI, 2002, 9 (1): : 41 - 46
  • [23] BCR-ABL and Src Family Kinases Induce YAP Tyrosine Phosphorylation Resulting in Survivin and Cyclin D1 Expression in Chronic Myeloid Leukemia Cells
    Hori, Toshiyuki
    Moriyama, Kenta
    BLOOD, 2019, 134
  • [24] 2-DEOXY-D-GLUCOSE INDUCES APOPTOSIS IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA AND SYNERGIZES WITH BCR/ABL TYROSINE KINASE INHIBITORS
    Barredo, Julio C.
    Leclerc, Guy J.
    Du, Jianfeng
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1035 - 1035
  • [25] Resistance to nilotinib in BCR-ABL positive cells is mediated by P-glycoprotein or Src kinase over expression
    Mahon, F. X.
    Lagarde, V
    Belloc, F.
    Turcq, B.
    Pocaly, M.
    Dupouy, M.
    Manley, P. W.
    Belanger, C.
    Leroy, C.
    Etienne, G.
    Roche, S.
    Pasquet, J. M.
    BULLETIN DU CANCER, 2008, 95 : S34 - S34
  • [26] Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl
    Schmidt, Nina
    Abendroth, Frank
    Vazquez, Olalla
    Hantschel, Oliver
    RSC CHEMICAL BIOLOGY, 2022, 3 (08): : 1008 - 1012
  • [27] Against erbB-2 over-expressing breast cancer cells or chronic myelogenous leukemia cells with bcr-abl translocation thorough destabilization of erbB-2 or bcr-abl oncoproteins.
    Soga, S
    Shiotsu, Y
    Sharma, SV
    Ikuina, Y
    Murakata, C
    Tamaoki, T
    Kurebayasi, J
    Schulte, TW
    Neckers, LM
    Akinaga, S
    CLINICAL CANCER RESEARCH, 2000, 6 : 4546S - 4546S
  • [28] Expression of cyclin D2 and D3 in lymphoid lesions
    Teramoto, N
    Pokrovskaja, K
    Szekely, L
    Polack, A
    Yoshino, T
    Akagi, T
    Klein, G
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (04) : 543 - 550
  • [29] Interleukin 2 gene transfer into and expression of functional Il-2 by bcr-abl positive dendritic cells
    Dietz, AB
    Litzow, MR
    Bulur, PA
    Vuk-Pavlovic, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 237 - 237
  • [30] BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
    Perrotti, D
    Cesi, V
    Trotta, R
    Guerzoni, C
    Santilli, G
    Campbell, K
    Iervolino, A
    Condorelli, F
    Gambacorti-Passerini, C
    Caligiuri, MA
    Calabretta, B
    NATURE GENETICS, 2002, 30 (01) : 48 - 58
12345